Disseminated cryptococcosis in a HIV-negative patient: Case report of a newly diagnosed hypertensive adult presenting with hemiparesis

Medical Mycology Case Reports - Tập 22 - Trang 4-7 - 2018
Raymond M. Wilson1, Nyambura Moremi2, Martha F. Mushi2, Oliver Bader3, Patrick S. Ngoya4, Bernard Desderius1, Peter Rambau5, Rodrick Kabangila1,6, Uwe Groß3, Stephen E. Mshana2
1Department of Internal Medicine, Bugando Medical Centre/Catholic University of Health and Allied Science, Mwanza, Tanzania
2Department of Microbiology and Immunology, Weill Bugando School of Medicine, Catholic University of Health and Allied sciences, Mwanza, Tanzania
3Institute of Medical Microbiology, University Medical Center Goettingen, Germany
4Department of Radiology, Bugando Medical Centre, Mwanza, Tanzania
5Department of Pathology, Weill Bugando School of Medicine, Mwanza, Tanzania
6Kamanga Medics Hospital, Mwanza, Tanzania

Tóm tắt

Từ khóa


Tài liệu tham khảo

Wajanga, 2011, Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study, J. Int. AIDS Soc., 14, 48, 10.1186/1758-2652-14-48

Chen, 2000, Epidemiology and host-and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand, Clin. Infect. Dis., 31, 499, 10.1086/313992

Kidd, 2004, A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada), Proc. Natl. Acad. Sci. USA, 101, 17258, 10.1073/pnas.0402981101

Moosa, 1997, Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients, Clin. Infect. Dis., 24, 131, 10.1093/clinids/24.2.131

Mitha, 2010, Disseminated Cryptococcosis in an HIV-negative patient in South Africa: the elusive differential diagnosis, J. Infect. Dev. Ctries., 4, 526, 10.3855/jidc.813

Lass-Flörl, 2006, Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology, Med. Mycol., 44, S319, 10.1080/13693780600779401

Sugita, 2017, Current status of taxonomy of pathogenic yeasts, Med. Mycol. J., 58, J77, 10.3314/mmj.17.010

Kiertiburanakul, 2006, Cryptococcosis in human immunodeficiency virus-negative patients, Int. J. Infect. Dis., 10, 72, 10.1016/j.ijid.2004.12.004

Schoffelen, 2013, Cryptococcus gattii induces a cytokine pattern that is distinct from other cryptococcal species, PloS One, 8, e55579, 10.1371/journal.pone.0055579

Williamson, 2017, Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy, Nat. Rev. Neurol., 13, 13, 10.1038/nrneurol.2016.167

Moodley, 2012, Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis, PloS One, 7, e52895, 10.1371/journal.pone.0052895

Kiggundu, 2014, Unmasking cryptococcal meningitis immune reconstitution inflammatory syndrome in pregnancy induced by HIV antiretroviral therapy with postpartum paradoxical exacerbation, Med. Mycol. case Rep., 5, 16, 10.1016/j.mmcr.2014.05.001

O'Meara, 2012, The Cryptococcus neoformans capsule: a sword and a shield, Clin. Microbiol. Rev., 25, 387, 10.1128/CMR.00001-12

Herkert, 2016, Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil, Eur. J. Clin. Microbiol. Infect. Dis., 35, 1803, 10.1007/s10096-016-2731-8

Kassi, 2016, Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV‐positive patients, Mycoses, 59, 811, 10.1111/myc.12539

Herkert, 2017, Ecoepidemiology of Cryptococcus gattii in developing countries, J. Fungi, 3, 62, 10.3390/jof3040062

Chen, 2012, Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death, Clin. Infect. Dis., 55, 789, 10.1093/cid/cis529